Summary
- Current Price
- As of today, IMUX price is $15.03, down -0.46% on
- Current Price All-Time High
- IMUX price is currently -99.89% below its historical high of $14,080.00 set on
- Market Cap
- IMUX current market cap is $205M, up +131.62% over the past 365 days
- PE Ratio
- IMUX PE ratio is unknown
- Revenue
- IMUX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for IMUX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Immunic, Inc. |
| Ticker | NASDAQ: IMUX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | imux.com |
| Employees | 90 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $15.03 | ||
| Price, 1D Change | -0.46% | |
| $205M | ||
| - | ||
| - | ||
| 1.64 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$6.24 | ||
| EPS, 1Y Change | +37.79% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VTL | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$6.24 | ||
| EPS Estimate | N/A | -$4.38 |
| EPS Est. Change | N/A | +29.77% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $15.03 | ||
| Price Target | - | $40.00 |
| Price Tgt. Change | - | +166.13% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.97 | -$10.03 | -938.96% | |
| -$0.66 | -$6.24 | -849.28% | |
| -$4.38 | N/A | +29.77% | |
| -$3.55 | N/A | +43.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $11.11M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +67.75% | ||
| -40.59% | ||
| +131.62% | ||
| -81.81% | ||
| 0.00% | ||
| 0.00% | ||
| +37.79% | ||
| -64.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $15.03 | ||
| $9.81 | ||
| $13.68 | ||
| $11.06 | ||
| $13.70 | ||
| $0.37 | ||
| 1.64 | ||
| $0.94 | ||
| 57.57 | ||
| 31.23% | ||
| 81.19% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$6.24 | ||
| $0.00 | ||
| - | ||
| -$103.23M | ||
| - | ||
| -$97.17M | ||
| - | ||
| -$103.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.02 | ||
| 0.75 | ||
| 0.75 | ||
| - | ||
| - | ||
| -45.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.35 | ||
| -0.17 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$6.67M | ||
| $15.48M | ||
| $24.05M | ||
| $22.87M | ||
| $30.73M | ||
| $30.62M | ||
| $107.00K | ||
| $470.00K | ||
| $10.14M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $97.17M | ||
| $103.23M | ||
| $0.00 | ||
| $21.25M | ||
| $168.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$85.81M | ||
| -$161.00K | ||
| $65.58M | ||
| $161.00K | ||
| -$85.97M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| Stifel | ||
| D. Boral Capital | → | |
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with IMUX
FAQ
What is the ticker symbol for Immunic, Inc.?
The ticker symbol for Immunic, Inc. is NASDAQ:IMUX
Does Immunic, Inc. pay dividends?
No, Immunic, Inc. does not pay dividends
What sector is Immunic, Inc. in?
Immunic, Inc. is in the Healthcare sector
What industry is Immunic, Inc. in?
Immunic, Inc. is in the Biotechnology industry
What country is Immunic, Inc. based in?
Immunic, Inc. is headquartered in United States
When did Immunic, Inc. go public?
Immunic, Inc. initial public offering (IPO) was on April 17, 2014
Is Immunic, Inc. in the S&P 500?
No, Immunic, Inc. is not included in the S&P 500 index
Is Immunic, Inc. in the NASDAQ 100?
No, Immunic, Inc. is not included in the NASDAQ 100 index
Is Immunic, Inc. in the Dow Jones?
No, Immunic, Inc. is not included in the Dow Jones index
When was Immunic, Inc. last earnings report?
Immunic, Inc.'s most recent earnings report was on May 13, 2026
When does Immunic, Inc. report earnings?
The next expected earnings date for Immunic, Inc. is August 6, 2026
Data Sources & References
- IMUX Official Website imux.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1280776/000128077626000005/0001280776-26-000005-index.htm
- IMUX Profile on Yahoo Finance finance.yahoo.com/quote/IMUX
- IMUX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imux